<p>(A) Percentage of chemokine receptor CCR5 in NKT cells gate (Vα24+Vβ11) in representative healthy subject and CVID patient (p<0.0001). (B) Percentage of chemokine receptors CXCR6, CCR5 and CD69 marker in NKT cells (p<0.001). (C) Percentage of chemokine receptor CCR5 and CD69 marker in NKT cells (p<0.001). Comparisons among groups were carried out using the Mann-Whitney non-parametric test.</p
<p>PBLs from the controls (N, <i>n</i> = 19) or patients with CRS (<i>n</i> = 18) were incubated wit...
<p>The figure shows the percentage of cells expressing NKp30 and NKp46 and normalized mean fluoresce...
<p>A Flow cytometry analysis of chemokine receptor expression on the cell surface of human MSCs. Che...
<p>(A) Representative flow cytometric analyses on PBMC, lymphocytes, CD3+ T cells and Vα24+Vβ11+ for...
<p>Representative dot plots showing the expression of CCR5 (A), CXCR3 (B) and CCR4 (C) on CD4 or CD8...
<p>(A) Percentage of CD4 marker in NKT cells (left) (p = 0.0055). (B) Absolute number of CD4 marker ...
Common variable immunodeficiency disorder (CVID) is the commonest cause of primary antibody failure ...
<p>Surface chemokine receptor expression on CD4+CD45RA- memory T cells from <i>ex-vivo</i> isolated ...
<p>The expression of CXCR3 (A) and CCR4 (B) was evaluated on conventional CD4<sup>+</sup> and CD8<su...
<p>(A) Representative dot plots of NK cells (CD3<sup>−</sup>CD56<sup>+</sup>) and their surface rece...
<div><p>One representative neonatal or adult sample of 5 is shown for each.</p> <p...
<p>(A) Representative dot plots depict NK activation receptor expression (NKp30, NKp44, NKp46, NKG2D...
<p>Box and whisker plots show the levels of CCL3 (A), CCL4 (B) and CCL5 (C) secreted over 3 days int...
<p>Surface NK markers were assessed by flow cytometry on CD56posCD16pos (56pos) and CD56negCD16pos (...
<p>(A) Flow cytometric dot-plots of expressions of CCR2, CCR3, CCR4, CCR5, and CCR6 on Th9 cells fro...
<p>PBLs from the controls (N, <i>n</i> = 19) or patients with CRS (<i>n</i> = 18) were incubated wit...
<p>The figure shows the percentage of cells expressing NKp30 and NKp46 and normalized mean fluoresce...
<p>A Flow cytometry analysis of chemokine receptor expression on the cell surface of human MSCs. Che...
<p>(A) Representative flow cytometric analyses on PBMC, lymphocytes, CD3+ T cells and Vα24+Vβ11+ for...
<p>Representative dot plots showing the expression of CCR5 (A), CXCR3 (B) and CCR4 (C) on CD4 or CD8...
<p>(A) Percentage of CD4 marker in NKT cells (left) (p = 0.0055). (B) Absolute number of CD4 marker ...
Common variable immunodeficiency disorder (CVID) is the commonest cause of primary antibody failure ...
<p>Surface chemokine receptor expression on CD4+CD45RA- memory T cells from <i>ex-vivo</i> isolated ...
<p>The expression of CXCR3 (A) and CCR4 (B) was evaluated on conventional CD4<sup>+</sup> and CD8<su...
<p>(A) Representative dot plots of NK cells (CD3<sup>−</sup>CD56<sup>+</sup>) and their surface rece...
<div><p>One representative neonatal or adult sample of 5 is shown for each.</p> <p...
<p>(A) Representative dot plots depict NK activation receptor expression (NKp30, NKp44, NKp46, NKG2D...
<p>Box and whisker plots show the levels of CCL3 (A), CCL4 (B) and CCL5 (C) secreted over 3 days int...
<p>Surface NK markers were assessed by flow cytometry on CD56posCD16pos (56pos) and CD56negCD16pos (...
<p>(A) Flow cytometric dot-plots of expressions of CCR2, CCR3, CCR4, CCR5, and CCR6 on Th9 cells fro...
<p>PBLs from the controls (N, <i>n</i> = 19) or patients with CRS (<i>n</i> = 18) were incubated wit...
<p>The figure shows the percentage of cells expressing NKp30 and NKp46 and normalized mean fluoresce...
<p>A Flow cytometry analysis of chemokine receptor expression on the cell surface of human MSCs. Che...